Katharine Barnard-Kelly, United Kingdom

Moderator of 1 Session

PARALLEL SESSION Webcast
Session Type
PARALLEL SESSION
Channel
Madrid
Date
20.02.2020, Thursday
Session Time
16:40 - 18:00

Presenter of 3 Presentations

ACCEPTABILITY OF BRIEF SELF-ADMINISTERED INJECTION TECHNIQUE ASSESSMENT QUESTIONNAIRE

Session Name
HUMAN FACTOR IN THE USE OF DIABETES TECHNOLOGY
Session Type
E-POSTER VIEWING (EXHIBITION HOURS)
Date
20.02.2020, Thursday
Session Time
09:30 - 15:30
Channel
E-Poster Area
Lecture Time
09:33 - 09:34

Abstract

Background and Aims

To assess the acceptability, relevance, usability and usefulness of a novel brief self-administered injection technique assessment tool.

Methods

The tool was developed using an iterative process in conjunction with people with diabetes and healthcare professionals. Focus groups and one-to-one interviews were held with three separate groups consisting of adults with type 1 diabetes, type 2 diabetes or healthcare professionals to elicit views and refine the tool ready for broader distribution to the target audience. Questions addressed ease of understanding, relevance, included questions and potential missing questions, feelings about diabetes and any discomfort or judgement felt when completing the tool.

Results

Five healthcare professionals and sixteen people with diabetes participated. Questions were reported to be clinically relevant by healthcare professionals and simple to complete. People with diabetes reported the tool to be ‘about the right length’, with the questions relevant and easy to read and follow. Adding ‘sometimes’ to response options was felt beneficial to more accurately reflect real-life diabetes management, along with clarification of medication type (i.e., different types of insulin and non-insulin medications). Overall, all groups felt this would be a useful tool to help people using injectable therapies refresh their technique for optimal dosing.

Conclusions

The tool was well-received by participants who made several suggestions for wording changes and clarification of individual questions. The resulting eleven item tool will be distributed to a wider target audience for reliability and psychometric analyses prior to final potential amendments and broader use.

Hide

What do the patients think of artificial pancreas?

Session Type
PARALLEL SESSION
Date
21.02.2020, Friday
Session Time
16:40 - 18:00
Channel
Rome
Lecture Time
17:30 - 17:55

Abstract

Background and Aims / Part 1

Automated insulin delivery systems represent cutting edge technologies aimed at improving glycaemic control. With varying levels of interaction required across different systems, this lecture will explore facilitators and barriers to effective engagement with automated insulin delivery systems from both research and user perspectives

Methods

Mixed methods approach to understanding the hopes, anxieties, experience and unmet needs related to automated insulin delivery systems. Quantitative and qualitative data will be presented from our program of research into the lived experience and psychosocial aspects of automated insulin delivery systems for users and HCPs.

Methods / Part 2

Mixed methods approach to understanding the hopes, anxieties, experience and unmet needs related to automated insulin delivery systems. Quantitative and qualitative data will be presented from our program of research into the lived experience and psychosocial aspects of automated insulin delivery systems for users and HCPs.

Results

Results will be presented reporting qualitative interviews and additional data. Data from different key stakeholder perspectives, i.e. adults, children, parents and partners living with Type 1 diabetes as well as healthcare professionals.

Results / Part 3

Results will be presented reporting qualitative interviews and additional data. Data from different key stakeholder perspectives, i.e. adults, children, parents and partners living with Type 1 diabetes as well as healthcare professionals.

Conclusions

Results will be discussed in the context of personalised diabetes management, individualised needs and challenges posed. Unmet needs will be examined in the context of healthcare delivery and support required by healthcare professionals and people living with diabetes.

Conclusions / Part 4

Results will be discussed in the context of personalised diabetes management, individualised needs and challenges posed. Unmet needs will be examined in the context of healthcare delivery and support required by healthcare professionals and people living with diabetes.
Hide

Onboarding and support needs for people with diabetes (PWD) and health care providers (HCPs)

Session Type
PARALLEL SESSION
Date
22.02.2020, Saturday
Session Time
08:30 - 10:00
Channel
Madrid
Lecture Time
08:30 - 08:50

Abstract

Background and Aims / Part 1

Diabetes technologies represent the most advanced devices possible to support optimal diabetes self-management and reduce risks of diabetes-related complications. Use of such devices, whilst beneficial for many, has proven unsatisfactory or too burdensome for others. High levels of drop-out or lack of engagement are two of the barriers to achieving the outcomes promised by such technologies. This lecture will examine the onboarding needs of people with diabetes and of healthcare professionals in the context of selecting appropriate diabetes technologies to meet the individual needs of each user.

Methods / Part 2

Evidence review of onboarding experience.

Methods

Evidence review of onboarding experience.

Results / Part 3

Data will be presented identifying the unmet needs of both healthcare professionals and people with diabetes in relation to onboarding of novel technologies.

Results

Data will be presented identifying the unmet needs of both healthcare professionals and people with diabetes in relation to onboarding of novel technologies.

Conclusions / Part 4

Traditional and novel approaches will be discussed

Conclusions

Traditional and novel approaches will be discussed

Hide